{"id":"W4205314496","doi":"10.1200/jco.2021.39.15_suppl.4030","title":"LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Internal medicine; Cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Cohort; Adverse effect; Phases of clinical research; Gastroenterology; Surgery; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00132815,0.0002198047,0.002217268,0.0001546329,0.00004011043,0.00001235584,0.0002362237,0.0001572053,0.0001508708],"category_scores_gemma":[0.004088468,0.0001271092,0.0002244791,0.000868406,0.0001206815,0.00009188648,0.00008698128,0.0009621158,0.000001912496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003579571,"about_ca_system_score_gemma":0.002379783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00121084,"about_ca_topic_score_gemma":0.002956253,"domain_scores_codex":[0.9946368,0.0006715207,0.00330577,0.0003422224,0.0007127111,0.0003309165],"domain_scores_gemma":[0.9936545,0.002118804,0.002585621,0.0003513719,0.001073285,0.0002164081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03530794,0.009663269,0.9247906,0.00001551533,0.001397913,0.0007084454,0.0005915156,0.0002057924,0.000009801436,4.943306e-7,0.001802836,0.02550587],"study_design_scores_gemma":[0.130609,0.02001004,0.8461679,0.0001871769,0.001552485,0.00001884219,0.0004701873,0.0002325325,0.00001632149,0.000002242172,0.0006425282,0.00009074715],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968253,0.0001955284,0.00001633339,0.001262421,0.0003507817,0.001096681,0.00002883125,0.000009991991,0.0002141522],"genre_scores_gemma":[0.9981444,0.0002847882,0.0002616129,0.0006009561,0.0004030995,0.00002081008,0.00004103477,0.00002231533,0.0002210008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09530111,"threshold_uncertainty_score":0.5183364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06555682777850554,"score_gpt":0.4240821736288863,"score_spread":0.3585253458503808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}